Patent 11926817 was granted and assigned to Nutcracker Therapeutics, Inc. on March, 2024 by the United States Patent and Trademark Office.
Apparatuses and methods are described herein for processing polynucleotides in a sealed path environment. The apparatuses include optical sensors to monitor operations and to track material usage for good manufacturing practice.